UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                    FORM 8-K


                                 CURRENT REPORT

                     Pursuant to Section 13 or 15(d) of the
                         Securities Exchange Act of 1934

         Date of Report (date of earliest event reported): June 25, 2013


                               CEL-SCI CORPORATION
                     -------------------------------------
             (Exact name of Registrant as specified in its charter)



     Colorado                        0-11503                  84-0916344
--------------------          ------------------------  -----------------------
(State or other jurisdiction   (Commission File No.)       (IRS Employer
of incorporation)                                        Identification No.)


                         8229 Boone Boulevard, Suite 802
                             Vienna, Virginia 22182
                 ---------------------------------------------
          (Address of principal executive offices, including Zip Code)



      Registrant's telephone number, including area code: (703) 506-9460
                                                          --------------


                                       N/A
                          ---------------------------
          (Former name or former address if changed since last report)



<PAGE>


   Item 5.07.     Submission of Matters to a Vote of Securities Holders.

      The annual meeting of CEL-SCI's shareholders was held on June 25, 2013. At
the meeting the following persons were elected as directors for the upcoming
year:

                Name                  Votes For           Votes Withheld
                ----                  ---------           --------------

            Maximilian de Clara       65,889,772           23,187,528
            Geert R. Kersten          75,355,564           13,721,736
            Alexander Esterhazy       77,880,404           11,196,896
            C. Richard Kinsolving     76,538,567           12,538,733
            Peter R. Young            77,823,272           11,254,028

      At the meeting the following were ratified by the shareholders.

     (1)  the   adoption  of  CEL-SCI's   Amended  and   Restated   Articles  of
Incorporation;

     (2) subject to the  determination  of  CEL-SCI's  directors  that a reverse
split would be in the best interest of CEL-SCI's shareholders, the adoption of a
reverse split of CEL-SCI's  common stock. A condition of the reverse stock split
is that the ratio of the reverse split will be determined by CEL-SCI's  Board of
Directors,  provided  that,  in any case,  the  reverse  split ratio will not be
greater  than 10 for 1. The Board of  Directors  may elect not to proceed with a
stock split without further action by the shareholders;

     (3) subject to the determination of CEL-SCI's directors that an increase in
CEL-SCI's  authorized  capital  would  be in  the  best  interest  of  CEL-SCI's
shareholders,   the  adoption  of  an   amendment   to  CEL-SCI's   Articles  of
Incorporation  such that CEL-SCI would be authorized to issue up to  800,000,000
shares of common  stock.  The Board of  Directors  may elect not to proceed with
increasing   CEL-SCI's   authorized   capital  without  further  action  by  the
shareholders; and

     (4) the  appointment  of BDO USA, LLP as CEL-SCI's  independent  registered
public accounting firm for the fiscal year ending September 30, 2013;

      The following is a tabulation of votes cast with respect to these
proposals:

                                  Votes
                    --------------------------------------          Broker
    Proposal         For          Against        Abstain           Non-Votes

      1.        208,502,239     27,744,607     13,469,847
      2.        156,067,768     89,649,626      3,999,299
      3.        190,425,399     48,391,841     10,899,453
      4.        236,020,249      5,940,917      7,755,527

       The adoption of CEL-SCI's 2013 Non-Qualified Stock Option Plan, which
provides that up to 20,000,000 shares of common stock may be issued upon the
exercise of options granted pursuant to the Non-Qualified Plan, did not receive
the required number of votes.

     As a result,  the annual  shareholders'  meeting has been adjourned to July
25, 2013, allowing  stockholders  additional time to vote on the adoption of the
2013  Non-Qualified  Plan. The meeting will reconvene on that date at 10:30 a.m.
at CEL-SCI's corporate office,  which is located at 8229 Boone Boulevard,  Suite
802, Vienna, Virginia 22182.

     The adoption of the 2013  Non-Qualified  Plan required the affirmative vote
of the holders of a majority of CEL-SCI's outstanding shares of common stock. In
addition,  brokers did not have discretionary  authority to vote on the proposal
and must therefore receive voting  instructions from beneficial owners of shares
held in street name in order for the shares to be voted. Although less than half
of CEL-SCI's  outstanding shares of common stock have been voted on the adoption
of the 2013  Non-Qualified  Plan, a significant  percentage of these shares have
been voted in favor of this proposal.

     As a result of the adoption of CEL-SCI's  Amended and Restated  Articles of
Incorporation,  the adoption of the 2013  Non-Qualified  Plan,  at the adjourned
meeting,  will  require the approval of a majority of votes cast with respect to
this matter.

     Despite  the  change  in  the  vote  required,  during  the  period  of the
adjournment, CEL-SCI will continue to solicit proxies from its stockholders with
respect  to  the  adoption  of  the  2013   Non-Qualified   Stock  Option  Plan.
Stockholders  who  have  not  already  done  so are  encouraged  to  vote on the
proposal.  Stockholders  who have already  voted need not take any action on the
proposal, although they may change their vote by executing a new proxy, revoking
a previously  given  proxy,  or attending  the  adjourned  meeting and voting in
person.

<PAGE>
                                       2

                                   SIGNATURES

      Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.


Date:  June 25, 2013                CEL-SCI CORPORATION



                                    By: /s/ Geert Kersten
                                        --------------------------------------
                                        Geert Kersten, Chief Executive Officer




































                                       3
[{"type": "8-K", "sequence": "1", "filename": "form8kitem507june-13.txt", "description": "8-K RE ITEM 5.07 ANNUAL MEETING", "secsgml_size_bytes": 6786}]
{"company-data": {"conformed-name": "CEL SCI CORP", "cik": "0000725363", "assigned-sic": "2836", "irs-number": "840916344", "state-of-incorporation": "CO", "fiscal-year-end": "0930"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "001-11889", "film-number": "13933853"}, "business-address": {"street1": "8229 BOONE BLVD .", "street2": "SUITE 802", "city": "VIENNA", "state": "VA", "zip": "22182", "phone": "7035069460"}, "mail-address": {"street1": "8229 BOONE BLVD.", "street2": "SUITE 802", "city": "VIENNA", "state": "VA", "zip": "22182"}, "former-company": {"former-conformed-name": "INTERLEUKIN 2 INC", "date-changed": "19880317"}}
UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT

                     Pursuant to Section 13 or 15(d) of the
                         Securities Exchange Act of 1934

         Date of Report (date of earliest event reported): June 25, 2013

                               CEL-SCI CORPORATION
                     -------------------------------------
             (Exact name of Registrant as specified in its charter)

     Colorado                        0-11503                  84-0916344
--------------------          ------------------------  -----------------------
(State or other jurisdiction   (Commission File No.)       (IRS Employer
of incorporation)                                        Identification No.)

                         8229 Boone Boulevard, Suite 802
                             Vienna, Virginia 22182
                 ---------------------------------------------
          (Address of principal executive offices, including Zip Code)

      Registrant's telephone number, including area code: (703) 506-9460
                                                          --------------

                                       N/A
                          ---------------------------
          (Former name or former address if changed since last report)
Item 5.07.     Submission of Matters to a Vote of Securities Holders.

      The annual meeting of CEL-SCI's shareholders was held on June 25, 2013. At
the meeting the following persons were elected as directors for the upcoming
year:

                Name                  Votes For           Votes Withheld
                ----                  ---------           --------------

            Maximilian de Clara       65,889,772           23,187,528
            Geert R. Kersten          75,355,564           13,721,736
            Alexander Esterhazy       77,880,404           11,196,896
            C. Richard Kinsolving     76,538,567           12,538,733
            Peter R. Young            77,823,272           11,254,028

      At the meeting the following were ratified by the shareholders.

     (1)  the   adoption  of  CEL-SCI's   Amended  and   Restated   Articles  of
Incorporation;

     (2) subject to the  determination  of  CEL-SCI's  directors  that a reverse
split would be in the best interest of CEL-SCI's shareholders, the adoption of a
reverse split of CEL-SCI's  common stock. A condition of the reverse stock split
is that the ratio of the reverse split will be determined by CEL-SCI's  Board of
Directors,  provided  that,  in any case,  the  reverse  split ratio will not be
greater  than 10 for 1. The Board of  Directors  may elect not to proceed with a
stock split without further action by the shareholders;

     (3) subject to the determination of CEL-SCI's directors that an increase in
CEL-SCI's  authorized  capital  would  be in  the  best  interest  of  CEL-SCI's
shareholders,   the  adoption  of  an   amendment   to  CEL-SCI's   Articles  of
Incorporation  such that CEL-SCI would be authorized to issue up to  800,000,000
shares of common  stock.  The Board of  Directors  may elect not to proceed with
increasing   CEL-SCI's   authorized   capital  without  further  action  by  the
shareholders; and

     (4) the  appointment  of BDO USA, LLP as CEL-SCI's  independent  registered
public accounting firm for the fiscal year ending September 30, 2013;

      The following is a tabulation of votes cast with respect to these
proposals:

                                  Votes
                    --------------------------------------          Broker
    Proposal         For          Against        Abstain           Non-Votes

      1.        208,502,239     27,744,607     13,469,847
      2.        156,067,768     89,649,626      3,999,299
      3.        190,425,399     48,391,841     10,899,453
      4.        236,020,249      5,940,917      7,755,527

       The adoption of CEL-SCI's 2013 Non-Qualified Stock Option Plan, which
provides that up to 20,000,000 shares of common stock may be issued upon the
exercise of options granted pursuant to the Non-Qualified Plan, did not receive
the required number of votes.

     As a result,  the annual  shareholders'  meeting has been adjourned to July
25, 2013, allowing  stockholders  additional time to vote on the adoption of the
2013  Non-Qualified  Plan. The meeting will reconvene on that date at 10:30 a.m.
at CEL-SCI's corporate office,  which is located at 8229 Boone Boulevard,  Suite
802, Vienna, Virginia 22182.

     The adoption of the 2013  Non-Qualified  Plan required the affirmative vote
of the holders of a majority of CEL-SCI's outstanding shares of common stock. In
addition,  brokers did not have discretionary  authority to vote on the proposal
and must therefore receive voting  instructions from beneficial owners of shares
held in street name in order for the shares to be voted. Although less than half
of CEL-SCI's  outstanding shares of common stock have been voted on the adoption
of the 2013  Non-Qualified  Plan, a significant  percentage of these shares have
been voted in favor of this proposal.

     As a result of the adoption of CEL-SCI's  Amended and Restated  Articles of
Incorporation,  the adoption of the 2013  Non-Qualified  Plan,  at the adjourned
meeting,  will  require the approval of a majority of votes cast with respect to
this matter.

     Despite  the  change  in  the  vote  required,  during  the  period  of the
adjournment, CEL-SCI will continue to solicit proxies from its stockholders with
respect  to  the  adoption  of  the  2013   Non-Qualified   Stock  Option  Plan.
Stockholders  who  have  not  already  done  so are  encouraged  to  vote on the
proposal.  Stockholders  who have already  voted need not take any action on the
proposal, although they may change their vote by executing a new proxy, revoking
a previously  given  proxy,  or attending  the  adjourned  meeting and voting in
person.
2

                                   SIGNATURES

      Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

Date:  June 25, 2013                CEL-SCI CORPORATION

                                    By: /s/ Geert Kersten
                                        --------------------------------------
                                        Geert Kersten, Chief Executive Officer

                                       3